tiprankstipranks
Biocytogen Pharmaceuticals (Beijing) Co. Ltd. Class H (HK:2315)
:2315
Hong Kong Market
2315
Biocytogen Pharmaceuticals (Beijing) Co. Ltd. Class H
RESEARCH TOOLSreports
Want to see HK:2315 full AI Analyst Report?

Biocytogen Pharmaceuticals (Beijing) Co. Ltd. Class H (2315) Income Statement

1 Followers

Biocytogen Pharmaceuticals (Beijing) Co. Ltd. Class H Income Statement

Last quarter (Q4 2025), Biocytogen Pharmaceuticals (Beijing) Co. Ltd. Class H's total revenue was ¥757.85M, an increase of 94.28% from the same quarter last year. In Q4, Biocytogen Pharmaceuticals (Beijing) Co. Ltd. Class H's net income was ¥125.20M. See Biocytogen Pharmaceuticals (Beijing) Co. Ltd. Class H’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
¥ 1.38B¥ 980.45M¥ 716.91M¥ 533.88M¥ 354.56M
Gross Profit
¥ 1.05B¥ 761.52M¥ 506.03M¥ 391.75M¥ 247.44M
Operating Expenses
¥ 766.99M¥ 597.15M¥ 776.32M¥ 997.75M¥ 772.89M
Depreciation and Amortization
¥ 160.46M¥ 169.18M¥ 182.44M¥ 138.74M¥ 128.10M
EBITDA
¥ 419.49M¥ 303.80M¥ -97.87M¥ -465.86M¥ -378.12M
Operating Income
¥ 278.60M¥ 164.37M¥ -270.29M¥ -530.44M¥ -505.82M
Other Income/Expenses
¥ -90.57M¥ -121.43M¥ -109.87M¥ -70.91M¥ -39.83M
Pretax Income
¥ 188.03M¥ 42.94M¥ -380.16M¥ -601.35M¥ -545.64M
Net Income
¥ 173.20M¥ 33.54M¥ -382.95M¥ -602.16M¥ -545.58M
Per Share Metrics
Basic EPS
¥ 0.43¥ 0.08¥ -0.96¥ -1.53¥ -1.38
Diluted EPS
¥ 0.43¥ 0.08¥ -0.96¥ -1.53¥ -1.38
Weighted Average Shares Outstanding
 400.08M 398.01M 398.31M 392.73M 396.69M
Weighted Average Shares Outstanding (Diluted)
 400.08M 398.01M 398.31M 392.73M 396.69M
Currency in CNY

Biocytogen Pharmaceuticals (Beijing) Co. Ltd. Class H Earnings and Revenue History